Sleep Medicine
Volume 13, Issue 2 , Pages 156-160, February 2012

Effects of nasal continuous positive airway pressure on panic disorder comorbid with obstructive sleep apnea syndrome

  • Yoshikazu Takaesu

      Affiliations

    • Department of Psychiatry, Tokyo Medical University, Tokyo, Japan
  • ,
  • Yuichi Inoue

      Affiliations

    • Department of Psychiatry, Tokyo Medical University, Tokyo, Japan
    • Department of Somnology, Tokyo Medical University, Tokyo, Japan
    • Japan Somnology Center, Neuropsychiatric Research Institute, Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Address: Department of Somnology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan. Tel.: +81 (0)3 3342 6111; fax: +81 (0)3 3342 7083.
  • ,
  • Yoko Komada

      Affiliations

    • Department of Somnology, Tokyo Medical University, Tokyo, Japan
    • Japan Somnology Center, Neuropsychiatric Research Institute, Tokyo, Japan
  • ,
  • Tatsuo Kagimura

      Affiliations

    • Department of Psychiatry, Tokyo Medical University, Tokyo, Japan
  • ,
  • Makio Iimori

      Affiliations

    • Department of Psychiatry, Tokyo Medical University, Tokyo, Japan

Received 2 March 2011; received in revised form 24 June 2011; accepted 12 October 2011.

Abstract 

Backgrounds

Both obstructive sleep apnea syndrome (OSAS) and panic disorder (PD) are common disorders that often coexist. Continuous positive airway pressure (CPAP) has been established as the first-line treatment for OSAS. In this study, we examined the efficacy of CPAP on PD comorbid with OSAS by conducting a randomized crossover study using sham CPAP as control.

Methods

PD patients (n=12) with an apnea hypopnea index (AHI) of 20/h or higher completed the study. At baseline, the subjects were asked to write their own records pertaining to the frequency of attacks and their score on the panic disorder severity scale (PDSS), and then they participated in the randomized crossover trial period, which measured optimal CPAP and sham CPAP set at 4cmH2O during nighttime sleep for each 4-week assignment.

Results

The frequency of panic attacks, total PDSS score, and the frequency of alprazolam use for alleviating the attack symptoms were significantly decreased during the optimal CPAP period than during the baseline period and the sham CPAP period. Among the PDSS subitems, the frequency of attacks, panic distress, work impairment, and social impairment showed significant improvements during the optimal pressure period.

Conclusion

Our results suggest that OSAS contributes to PD aggravation, and a combination of pharmaceutical treatment for PD and OSAS-specific treatments such as CPAP could be recommended for patients with PD comorbid with OSAS.

Abbreviations: OSAS, Obstructive sleep apnea syndrome, PD, panic disorder, CPAP, continuous positive airway pressure, PSG, polysomnography, AHI, apnea hypopnea index, EEG, electroencephalogram, BMI, body mass index, PDSS, panic disorder severity scale, CBT, cognitive-behavioral therapy

Keywords: Sleep apnea syndrome, Panic disorder, Continuous positive airway pressure, Panic attack, Panic disorder severity scale, Apnea hypopnea index

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was performed at the Neuropsychiatric Research Institute, Tokyo, Japan. Financial support for this study was provided by Health Science Grants from the Ministry of Health and Welfare, Japan.

PII: S1389-9457(11)00327-3

doi:10.1016/j.sleep.2011.10.016

Sleep Medicine
Volume 13, Issue 2 , Pages 156-160, February 2012